Insider · CIK 0001997920
Ram Aiyar
Files at KRRO (Korro Bio, Inc.). First filing Jun 2, 2026, latest Aug 5, 2026.
In brief
Ram Aiyar files SEC Form 4 as CEO, president and director at KRRO (Korro Bio, Inc.). Since Jun 2, 2026, Ram Aiyar has reported 0 open-market buys worth $0 and 2 open-market sells worth $260k, the latest filed on Aug 5, 2026.
A track record needs three past buys with six months of prices behind them; Ram Aiyar has 0, so none is measured yet.
The newest scored trade: sold $63k of KRRO on Aug 4, 2026, filed Aug 5, 2026, scored 41 (moderate). In the last 12 months: 0 buys worth $0 and 2 sells worth $260k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KRRO: Korro Bio, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | Korro Bio, Inc. | $63k 5,802 shares | -8% | +115% from low-78% from high | |
| 50Moderate | Korro Bio, Inc. | $197k 15,152 shares | -17% | +154% from low-74% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 4, 2026 | KRRO Korro Bio, Inc. | 5,802 0.04% of outstanding | $663k | Aug 4, 2026 | $197k |
| May 29, 2026 | KRRO Korro Bio, Inc. | 15,152 0.11% of outstanding | $197k | May 29, 2026 | none |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | KRRO Korro Bio, Inc. | SOpen-market sale Common Stock | -5,802 | $10.84 | $63k | 69,046 | Aug 5, 2026 |
| May 29, 2026 | KRRO Korro Bio, Inc. | SOpen-market sale Common Stock | -15,152 | $12.98 | $197k | 74,848 | Jun 2, 2026 |
| May 26, 2026 | KRRO Korro Bio, Inc. | AGrant or award Common Stock | +50,000 | $12.33 | $617k | 90,000 | May 28, 2026 |
| Feb 2, 2026 | KRRO Korro Bio, Inc. | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 40,000 | Feb 3, 2026 |
| Feb 2, 2026 | KRRO Korro Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +80,000 | $0.00 | $0 | 80,000 | Feb 3, 2026 |
| Feb 3, 2025 | KRRO Korro Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Feb 5, 2025 |
| Nov 3, 2023 | KRRO Korro Bio, Inc. | AGrant or award Common Stockindirect: THE RAM AIYAR IRREVOCABLE TRUST | +4,613 | - | - | 4,613 | Nov 7, 2023 |
| Nov 3, 2023 | KRRO Korro Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +136,234 | - | - | 136,234 | Nov 7, 2023 |
| Nov 3, 2023 | KRRO Korro Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +36,769 | - | - | 36,769 | Nov 7, 2023 |
| Nov 3, 2023 | KRRO Korro Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,130 | - | - | 30,130 | Nov 7, 2023 |
| Nov 3, 2023 | KRRO Korro Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +156,760 | $0.00 | $0 | 156,760 | Nov 7, 2023 |
Questions about Ram Aiyar
Answered from the filings on this page, as of the latest one.
Is Ram Aiyar buying or selling?
In the last 12 months Ram Aiyar reported 0 open-market buys worth $0 and 2 open-market sells worth $260k on SEC Form 4; the latest was sold $63k of KRRO on Aug 4, 2026. Grants, option exercises and tax withholding are not counted.
How did Ram Aiyar's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ram Aiyar has 0.
Where does Ram Aiyar file Form 4?
Ram Aiyar has filed Form 4 at KRRO (Korro Bio, Inc.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.